Options Brief: The Medicines Company (MDCO)

MDCO – Medicines Co. – Global pharmaceutical company, Medicines Co., popped onto our ‘hot by options volume’ market scanner in the first half of the trading session after one investor utilized both call and put options to establish a bullish stance on the stock. Medicines’ shares increased 0.40% today to arrive at $7.47 by 12:38 pm (ET). It looks like the optimistic options player sold 5,000 puts at the October $5.0 strike for a premium of $0.35 apiece in order to halve the cost of buying 5,000 calls at the nearer-term July $10 strike for a premium of $0.70 each. The net cost of getting long the out-of-the-money calls is reduced to $0.35 per contract, thus positioning the investor to make money if shares of the underlying stock surge 38.55% over the current price to exceed the effective breakeven point on the calls at $10.35 by July expiration. The short sale of the puts implies the investor does not expect MDCO shares to plummet through $5.00 by October expiration. But, if the stock were to plunge 33% from the current price to push the puts in-the-money, the trader is obliged to have Medicines’ shares put to him at an effective price of $4.65 each. We note that shares of the pharmaceutical company have not traded under $5.00 in the last five years, but shares did rally above $10.35 as recently as March 17, 2010.

About Andrew Wilkinson 1023 Articles

Affiliation: Interactive Brokers

Andrew Wilkinson is the senior market analyst at Interactive Brokers Group, where he provides daily commentary and analysis on U.S. equity options trading throughout the trading day. Andrew provides webinars designed to explain option-related trading scenarios covering futures, fixed income, forex and equities.

Interactive Brokers: Interactive Brokers offers direct market access to around 80 electronic global markets from a single account. Successful traders and investors understand that superior technology and lower trading costs can result in greater returns. For 32 years we have been building direct access trading technology that delivers real advantages to professionals worldwide. With consolidated equity capital of US $4.4 billion, IB and its affiliates exceed 1,000,000 trades per day. In addition, our prudent and conservative risk policies make Interactive Brokers a safe haven for your money. Discover some of the reasons why IB, the largest independent US broker/dealer, is the professional traders' and investors' choice.

Visit: Interactive Brokers

Be the first to comment

Leave a Reply

Your email address will not be published.


*